Lv5
930 积分 2022-06-10 加入
GSK3β(high)/NFATc1(high) subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair
25天前
已关闭
FGFR rearrangements: oncogenic drivers and therapeutic targets
28天前
已关闭
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
28天前
已完结
Apoptosis in Cancer Biology and Therapy
30天前
已完结
FGFR Inhibition in Urothelial Carcinoma
1个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers
1个月前
已完结
FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma
1个月前
已完结
Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?
1个月前
已完结
Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications
1个月前
已完结
皖公网安备34019202002308
